At Toxikon, we are dedicated to collaborating with you and your suppliers to ensure that the products you develop are effective and safe. We deliver exceptional expertise and service that is timely, efficient and cost-effective. 

Connect With Us

    

Our Services

 News & Events   

  • Toxikon at Arvo 2015 »more
  • Toxikon at SOT/ToxExpo 2015 »more
  • Biologics, Biosimilars and Biobetters - Toxikon Webinar »more
  • Toxikon to Present and Exhibit at MD&M West in Anaheim »more
  • Toxikon to Present and Exhibit at PepTalk in San Diego »more
  • Extractable and Leachable Compounds - Toxikon Webinar »more
Link to Toxikon Belgium Site
Preclinical CRO | Preclinical Development Services from Concept to
toxicology (acute, subchronic, and chronic toxicity, reproductive toxicity, genetic toxicology, and carcinogenicity), pharmacokinetics, toxicokinetics, bioavailability, ADME, chemical characterization, impurities analysis and synthesis, bioanalytical, and microbiology/virology, pharmaceutical, medical device, or biotech company, anticancer or antiviral compound, ocular studies, ophthalmic, disease models, Analytical and Bioanalytical Chemistry, Biocompatibility Assessment, biocompatibility Safety Evaluation Guidelines, Cell and Molecular Biology, Disease Models, Efficacy and Surgical Research Services, Extractables and Leachables, microbiology Ocular Drug Program Pathology R&D and Discovery
Toxikon is a preclinical contract research organization (CRO) dedicated to collaborating with biotech, pharmaceutical and medical device researchers to deliver exceptional drug research and development services from concept to final product.